FDA Adverse Event Malfunction Summary report: N

CEPHEID XPERT XPRESS SARS-COV-2/FLU/RSV

MDR report key: 12824663 · Received November 16, 2021

Report

Report Number
3004530258-2021-00425
Event Type
Malfunction
Date Received
November 16, 2021
Date of Event
October 31, 2021
Report Date
November 15, 2021
Manufacturer
CEPHEID
Product Code
QJR
PMA / PMN Number
EUA200453
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

US CUSTOMER CONTACTED CEPHEID TO DISCUSS PATIENT RESULTS FOR XPERT XPRESS SARS-COV-2/FLU/RSV. CUSTOMER COLLECTED SAMPLE 1 FROM PATIENT-1 ON (B)(6) 2021, WHICH WAS TESTED ON XPERT XPRESS SARS COV-2/FLU/RSV AND RESULTED AS SARS-COV-2 NEGATIVE, FLUA NEGATIVE, FLUB NEGATIVE RSV NEGATIVE (REPORTED TO THE PHYSICIAN). SAMPLE 1 REPEAT-1 OCCURRED ON (B)(6)2021 AND TESTED ON BIOFIRE RESPIRATORY PANEL 2.1, WHICH RESULTED IN DETECTED RESPIRATORY SYNCYTIAL VIRUS (REPORTED TO THE PHYSICIAN). THE ROOT CAUSE WAS DETERMINED TO BE TARGET/S NEAR LIMIT OF DETECTION OR NEAR CUT-OFF. THERE IS NO EVIDENCE OF PRODUCT MALFUNCTION AND THERE WAS NO REPORTED HARM. AS PER SECTION 3 OF XPERT XPRESS SARS-COV-2/FLU/RSV, EUA IFU; NEGATIVE RESULTS DO NOT PRECLUDE SARS-COV-2 INFECTION AND SHOULD NOT BE USED AS THE SOLE BASIS FOR TREATMENT OR OTHER PATIENT MANAGEMENT DECISIONS. NEGATIVE RESULTS MUST BE COMBINED WITH CLINICAL OBSERVATIONS, PATIENT HISTORY, AND EPIDEMIOLOGICAL INFORMATION. NOTE FOR SECTION DEVICE EVALUATED BY MANUFACTURER - ANSWER OF NO IS DUE TO THE SINGLE USE OF THE XPERT XPRESS SARS-COV-2/FLU/RSV, AND THE UNAVAILABILITY OF THAT PRODUCT LOT TO BE RETURNED TO CEPHEID.

Description of Event or Problem · 0

US CUSTOMER CONTACTED CEPHEID TO DISCUSS PATIENT RESULTS FOR XPERT XPRESS SARS-COV-2/FLU/RSV. CUSTOMER COLLECTED SAMPLE 1 FROM PATIENT-1 ON (B)(6) 2021, WHICH WAS TESTED ON XPERT XPRESS SARS COV-2/FLU/RSV AND RESULTED AS SARS-COV-2 NEGATIVE, FLUA NEGATIVE, FLUB NEGATIVE RSV NEGATIVE (REPORTED TO THE PHYSICIAN). SAMPLE 1 REPEAT-1 OCCURRED ON (B)(6)2021 AND TESTED ON BIOFIRE RESPIRATORY PANEL 2.1, WHICH RESULTED IN DETECTED RESPIRATORY SYNCYTIAL VIRUS (REPORTED TO THE PHYSICIAN). REVIEW OF DATA PROVIDED BY THE CUSTOMER SHOWED NO EVIDENCE OF PRODUCT MALFUNCTION AND THERE WAS NO KNOWN HARM TO PATIENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1717573 CEPHEID XPERT XPRESS SARS-COV-2/FLU/RSV COVID-19 RT-PCR TEST QJR CEPHEID 1000283424

Patients

Seq Age Sex Outcome Treatment
1 Unknown